Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Douglas Adkins, M.D.
Washington University School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sanford Worthington Medical Center
Worthington, Minnesota, United States
Steven Powell, M.D.Not, yet, recruiting - Saint Luke'S Hospital
Kansas City, Missouri, United States
Withdrawn - Washington University School of Medicine
St Louis, Missouri, United States
Douglas Adkins, M.D.Esther Lu, Ph.D.Peter Oppelt, M.D.Recruiting - Sanford Roger Maris Cancer Center
Fargo, North Dakota, United States
Daniel Almquist, M.D.Recruiting - Sanford Medical Center
Sioux Falls, South Dakota, United States
Steven Powell, M.D.Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Apr 2022
- Primary completion
- 28 Feb 2028
- Completion
- 28 Feb 2028
- Last update posted
- 19 May 2026
- Registered enrollment
- 81
- Registry id
- NCT04966481
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.